Sign In

Terri Roberson

Senior Director, Clinical Development, Immunology

Professional Background

Terri A. Roberson is a highly accomplished professional in the pharmaceutical and healthcare sector, with an extensive background in clinical development, operations, and project management. As the Senior Director of Clinical Development in Immunology at Eli Lilly and Company, Terri currently leads innovative initiatives that drive advancements in the field of immunology. With her robust experience at Eli Lilly, she has significantly contributed to the company’s success by overseeing crucial projects and enhancing operational efficiency.

Prior to her current role, Terri held several prominent positions at Eli Lilly, demonstrating her leadership and strategic capabilities. As the Chief Operating Officer for Clinical Design, Delivery, and Analytics, she was pivotal in refining clinical operations to ensure the smooth delivery of therapeutic solutions. Furthermore, her role as Chief Operating Officer in Global Patient Safety underscored her commitment to patient welfare and safety, which is a cornerstone of the pharmaceutical industry.

Terri's career journey also includes a notable tenure at AbbVie, where she served as the Sr. Director for Humira & Immunology Clinical Program Development. Here, she played a critical role in the development and management of one of the most successful medications in history. Her expertise in clinical program development and her ability to navigate complex clinical landscapes have made her a valuable asset in any organization she has been part of.

With an early career starting as a Clinical Project Manager at Eli Lilly, she steadily rose through the ranks, illustrating her dedication and proficiency in project management. Her operational insight was honed further during her time at Covance, where she laid the groundwork for her future leadership roles.

Education and Achievements

Terri’s educational background is as impressive as her career trajectory. She holds a Bachelor of Science in Medical Technology from Purdue University, which provided her with a strong foundation in the sciences, essential for her career in clinical development and operations. Later, she pursued an MBA in Business from the University of Indianapolis, equipping her with crucial knowledge and skills in management and business strategies. This combination of technical and business education has been indispensable in her roles within the pharmaceutical industry.

Over the years, Terri has been recognized for her leadership and impact on the healthcare sector. Her commitment to innovation, best practices in clinical operations, and focus on patient safety has earned her respect and recognition among peers in the industry. As a mentor and leader, she has inspired many upcoming professionals to pursue excellence in their careers.

Achievements

Throughout her illustrious career, Terri A. Roberson has achieved several milestones that underscore her expertise and leadership abilities. She has successfully led multiple clinical projects that resulted in the approval of critical therapies in immunology, thereby enhancing patient care globally.

Her strategic vision and operational acumen have allowed her to streamline processes within teams, fostering collaboration and efficiency that have positively impacted project timelines and outcomes. Additionally, her roles have required her to be at the forefront of regulatory compliance, ensuring that all clinical activities meet the highest standards of safety and efficacy.

Terri A. Roberson's contributions extend beyond her organizational roles, as she remains actively involved in industry discussions and forums, advocating for advancements in clinical research methodologies and patient-centered care. Her passion for enhancing healthcare outcomes is evident in her collaborative efforts and persistence in pushing the boundaries of clinical development.

In summary, Terri A. Roberson is a distinguished figure in the pharmaceutical industry, possessing a wealth of knowledge and experience in clinical development, operations, and patient safety. Her educational background, combined with an impressive career trajectory, positions her as a leading authority in the field. She is committed to driving innovation and improving patient outcomes through her work, making her an invaluable asset to any organization committed to healthcare advancement.

Related Questions

How did Terri A. Roberson develop her expertise in clinical development and operations within the pharmaceutical industry?
What impact has Terri A. Roberson had in the field of immunology during her time as Senior Director at Eli Lilly and Company?
How has Terri A. Roberson's education at Purdue University and the University of Indianapolis contributed to her successful career in healthcare?
What notable innovations or projects has Terri A. Roberson led during her extensive tenure at Eli Lilly and Company?
In what ways does Terri A. Roberson advocate for patient safety in her roles within the pharmaceutical sector?
T
Add to my network

Location

Greater Indianapolis